Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A2 | P23975 | 1/20 | 0.51 |
| ▸ | NMUR2 | Q9GZQ4 | 5/20 | 0.51 |
| ▸ | NMUR1 | Q9HB89 | 4/20 | 0.51 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.50 |
| ▸ | NTSR2 | O95665 | 1/20 | 0.49 |
| ▸ | NTSR1 | P30989 | 1/20 | 0.49 |
| ▸ | EPHA2 | P29317 | 2/20 | 0.48 |
| ▸ | CXCL8 | P10145 | 1/20 | 0.48 |
| ▸ | CALCRL | Q16602 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29607994 | 0.85 | SLC6A2 (0.59) | SLC6A2OPRM1 | |
| SCHEMBL31267154 | 0.85 | NMUR2 (0.61) | NMUR2NMUR1NTSR2NTSR1 | |
| SCHEMBL30512601 | 0.82 | NTSR1 (0.58) | NTSR2NTSR1EPHA2 | |
| SCHEMBL31108650 | 0.82 | SLC6A2 (0.59) | SLC6A2OPRM1NTSR2NTSR1 | |
| SCHEMBL29591081 | 0.81 | NTSR1 (0.53) | SLC6A2NMUR2NMUR1OPRM1NTSR2 | |
| SCHEMBL29760530 | 0.81 | SLC6A2 (0.60) | SLC6A2NMUR2NMUR1NTSR2NTSR1 | |
| SCHEMBL30444233 | 0.81 | SLC6A2 (0.57) | SLC6A2NMUR2OPRM1NTSR2NTSR1 | |
| SCHEMBL13311989 | 0.81 | CALCRL (0.56) | SLC6A2OPRM1EPHA2CALCRL | |
| SCHEMBL31239042 | 0.80 | NTSR1 (0.58) | SLC6A2NMUR2NMUR1OPRM1NTSR2 | |
| SCHEMBL30785408 | 0.80 | ACE (0.59) | SLC6A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113151387-B | Cod skin collagen peptide with oxidation resistance and immunity enhancement functions and preparation method thereof | 安徽国肽生物科技有限公司 | 2022-08-16 | — | — | CN | disclosed |